Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Down 71.4% in April

Mangoceuticals, Inc. (NASDAQ:MGRX) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 197,600 shares, a drop of 71.4% from the March 31st total of 692,100 shares. Based on an average daily volume of 904,900 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.5% of the company’s stock are sold short.

Mangoceuticals Trading Up 3.4 %

NASDAQ:MGRX traded up $0.01 during mid-day trading on Thursday, hitting $0.28. The company had a trading volume of 410,119 shares, compared to its average volume of 906,703. The business has a fifty day simple moving average of $0.22 and a 200-day simple moving average of $0.39. Mangoceuticals has a 1 year low of $0.14 and a 1 year high of $2.38.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It provides erectile dysfunction and hair growth products under the Mango and Mango GROW brand names. The company also offers direct-to-clinics solutions comprising PRIME, an oral testosterone replacement therapy (TRT) prescription product by doctors and medical practitioners to their patients directly from their offices, clinics, and brick and mortar locations.